Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
HUMA

Updated 10/6/2026, 8:56 AM ET.

HUMA

Humacyte, Inc.

Buy$5,620

Jones Keith Anthony

Director

10,000 shat $0.56Filed Sep 15, 4:05 PM ETFiling
HUMA

Humacyte, Inc.

Buy$6,930

Jones Keith Anthony

Director

10,000 shat $0.69Filed Aug 21, 4:05 PM ETFiling
HUMA

Humacyte, Inc.

Buy$17,820

Jones Keith Anthony

Director

30,000 shat $0.59Filed Aug 19, 4:00 PM ETFiling

Read from public SEC filings. Not financial advice.